EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome

Raphaele Seror, Philippe Ravaud, Xavier Mariette, Hendrika Bootsma, Elke Theander, Arne Hansen, Manel Ramos-Casals, Thomas Doerner, Stefano Bombardieri, Eric Hachulla, Johan G. Brun, Aike A. Kruize, Sonja Praprotnik, Matija Tomsic, Jacques-Eric Gottenberg, Valerie Devauchelle, Salvatore Devita, Cristina Vollenweider, Thomas Mandl, Athanasios TzioufasSteven Carsons, Alain Saraux, Nurhan Sutcliffe, Claudio Vitali, Simon J. Bowman

Research output: Contribution to journalArticlepeer-review

254 Citations (SciVal)


Objectives To develop a score for assessment of patients' symptoms in primary Sjogren's syndrome (SS): the EULAR SS Patient Reported Index (ESSPRI). Methods Dryness, pain, somatic and mental fatigue were identified as the main symptoms of patients with primary SS, in studies developing the Profile of Fatigue and Discomfort (PROFAD) and Sicca Symptoms Inventory (SSI). It was suspected that a single 0-10 numerical scale for each domain was sufficient to assess these symptoms. These four scales were gathered to form the ESSPRI. 230 patients, from 12 countries completed the ESSPRI, SSI and PROFAD questionnaires and a 0-10 patient global assessment (PGA). Correlations between each symptom and PGA were obtained. Multiple regression modelling, using PGA as 'gold standard' was used to select domains and estimate their weights. Results PGA had good correlation with dryness, limb pain, fatigue and mental fatigue (r=0.49-0.59, all p<0.0001), but correlated less well with individual dryness features. In multivariate analysis, dryness, limb pain and fatigue, but not mental fatigue, were significantly associated with PGA; weights derived from the regression were identical for these three domains. Thus, ESSPRI was redefined as the mean of the three scales: dryness, limb pain and fatigue. Lastly, ESSPRI significantly correlated with PGA (r=0.70), PROFAD (r=0.73) and SSI (r=0.66). Conclusion ESSPRI is a very simple index designed to measure patients' symptoms in primary SS. It has good construct validity and is well correlated with SSI and PROFAD. ESSPRI should now be validated for use as an outcome measure in clinical trials.
Original languageEnglish
Pages (from-to)968-972
JournalAnnals of the Rheumatic Diseases
Issue number6
Publication statusPublished - 2011

Bibliographical note

The information about affiliations in this record was updated in December 2015.
The record was previously connected to the following departments: Internal Medicine Research Unit (013242520), Emergency medicine/Medicine/Surgery (013240200)

Subject classification (UKÄ)

  • Rheumatology and Autoimmunity


Dive into the research topics of 'EULAR Sjogren's Syndrome Patient Reported Index (ESSPRI): development of a consensus patient index for primary Sjogren's syndrome'. Together they form a unique fingerprint.

Cite this